ebomi
Colour theme
Sign in
Insider · CIK 0001276550

Loughlin James J

CIK 0001276550 Name as filed on the most recent filing

Filed as Loughlin James J (18)

28 transaction lines · from 18 filings · filed 2004-09-22 to 2019-02-11 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

28 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2019-02-07 S, Open-market sale Celgene Corp /DE/CELG 2,048,324, disposed Open Form 4 filing 0001415889-19-000144
2018-06-04 S, Open-market sale Celgene Corp /DE/CELG 1,401,540, disposed Open Form 4 filing 0001415889-18-000872
2018-03-12 S, Open-market sale Celgene Corp /DE/CELG 851,093, disposed Open Form 4 filing 0001209191-18-019209
2017-06-26 S, Open-market sale Celgene Corp /DE/CELG 2 lines 2,471,045, disposed Open Form 4 filing 0001209191-17-041954
2017-05-01 S, Open-market sale Celgene Corp /DE/CELG 1,147,000, disposed Open Form 4 filing 0001209191-17-029190
2017-03-06 P, Open-market purchase Edge Therapeutics, Inc.EDGE 27,720, acquired Open Form 4 filing 0001127602-17-010543
2016-08-23 S, Open-market sale Celgene Corp /DE/CELG 3,137,750, disposed Open Form 4 filing 0001209191-16-138482
2016-03-21 P, Open-market purchase InspireMD, Inc.NSPR 29,500, acquired Open Form 4 filing 0001615774-16-004585
2016-03-11 P, Open-market purchase Edge Therapeutics, Inc.EDGE 7 lines 22,901, acquired Open Form 4 filing 0001127602-16-046331
2016-02-22 S, Open-market sale Celgene Corp /DE/CELG 218,652, disposed Open Form 4 filing 0001209191-16-101961
2015-10-06 P, Open-market purchase Edge Therapeutics, Inc.EDGE 77,000, acquired Open Form 4 filing 0001140361-15-037188
2014-08-22 S, Open-market sale Celgene Corp /DE/CELG 1,825,000, disposed Open Form 4 filing 0001209191-14-054432
2013-04-16 P, Open-market purchase InspireMD, Inc.NSPR 30,000, acquired Open Form 4 filing 0001144204-13-022470
2012-06-22 P, Open-market purchase Celgene Corp /DE/CELG 36,174, acquired Open Form 4 filing 0001209191-12-035087
2009-05-06 P, Open-market purchase Celgene Corp /DE/CELG 23,742, acquired Open Form 4 filing 0001209191-09-025104
2006-07-25 P, Open-market purchase Alfacell CorpACEL 2 lines 15,268, acquired Open Form 4 filing 0001005477-06-003634
2005-05-19 P, Open-market purchase Datascope CorpDSCP 2 lines 29,800, acquired Open Form 4 filing 0001140361-05-003865
2004-09-22 P, Open-market purchase Alfacell CorpACEL 5,060, acquired Open Form 4 filing 0001005477-04-003382
2004-09-21 P, Open-market purchase Alfacell CorpACEL 6,300, acquired Open Form 4 filing 0001005477-04-003382

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 19
  • Open-market sale 9
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. LOUGHLIN JAMES J, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001276550

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.